drugset / Trial / NCT01698697
Comparison of Two Insulin Aspart Formulations in Healthy Volunteers
RandomizedCrossoverDouble-blindTreatment
Summary
This trial is conducted in Africa. The aim of this trial is to determine if a new formulation (U200) of insulin aspart containing 200 U/mL is bioequivalent to that of a marketed insulin aspart formulation (U100).
Timeline
- Start
- 2002-09-02
- Primary completion
- 2002-10-18
- Completion
- 2002-10-18
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | insulin aspart | Protein / enzyme biologic | 0.029 iu/kg | Subcutaneous |